Related Experiment Video

Updated: Jul 5, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

The role of Herceptin in early breast cancer

Ashok Subramanian1, Kefah Mokbel

  • 1St Georges Hospital, Blackshaw Road, Tooting, SW17 0QT, UK. ashsubramanian@hotmail.com.

International Seminars in Surgical Oncology : ISSO
|April 30, 2008
PubMed

Insights

Herceptin targets HER2 overexpression in breast cancer, marking a significant advancement in targeted therapy. This review explores HER2 and Herceptin

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Breast cancer treatment has seen major advancements, including Tamoxifen and multidisciplinary teams (MDT).
  • Targeted therapies represent a new frontier, focusing on specific molecular abnormalities in tumor cells.
  • HER2 overexpression is a key factor in certain breast cancer types.

Purpose of the Study:

  • To review the nature of HER2 overexpression in breast cancer.
  • To examine the role of Herceptin in treating early breast cancer.
  • To highlight the significance of targeted therapy in oncology.

Main Methods:

  • Literature review focusing on HER2 overexpression.
  • Analysis of clinical data and studies on Herceptin efficacy.
  • Exploration of the molecular mechanisms of targeted cancer therapy.

Main Results:

  • Herceptin demonstrates significant success as a targeted therapy for HER2-positive breast cancer.
  • Understanding HER2 overexpression is crucial for effective treatment selection.
  • Targeted therapies offer a more precise approach compared to traditional chemotherapy.

Conclusions:

  • Herceptin is a pivotal development in breast cancer treatment, particularly for HER2-positive cases.
  • Targeted therapy, exemplified by Herceptin, is transforming oncology.
  • Further research into molecular targets will continue to advance cancer care.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...